Popular Categories
Join Now! New HHS Hepatitis C Medicaid Affinity Group
The Office of HIV/AIDS and Infectious Disease Policy (OHAIDP), in collaboration with the Centers for Medicare and Medicaid Services...
Oct 11, 2017 | Kim Rodgers
HHS Blog: When it Comes to Curing Hepatitis C, Your Health Care Provider May Not...
This blog, written by Richard Wolitski, Ph.D., Director, Office of HIV/AIDS and Infectious Disease Policy, U.S. Department of Health...
Sep 28, 2017 | Kim Rodgers
HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C...
The American Association for the Study of Liver Diseases (AASLD) and the Infectious Diseases Society of America (ISDA) released...
Sep 22, 2017 | Kim Rodgers
Report: Science over Stigma: The Public Health Case Against HCV Treatment Sobriety...
In response to the introduction of effective, short-course, curative hepatitis C (HCV) treatments, shifting HCV trends nationwide, and...
Sep 14, 2017 | Kim Rodgers
Funding Opportunity: Projects Addressing HIV/HCV in Context of Opioid Epidemic
amfAR, “The Foundation for AIDS Research,” is seeking grant applicants for a funding opportunity of up to $70,000. The...
Aug 18, 2017 | Anastasia Sonneman
NASTAD Call to Action: Urgent Response to Nation’s Hepatitis C Epidemic
In response to the recent National Academies of Sciences, Engineering, and Medicine’s (NASEM) release of A National Strategy for the...
Aug 01, 2017 | Kim Rodgers
NACCHO Launches Hepatitis C Public Health Detailing Kit
On this World Hepatitis Day, NACCHO is pleased to launch its Hepatitis C Public Health Detailing Kit. Hepatitis C (HCV) presents a...
Jul 28, 2017 | Kim Rodgers
World Hepatitis Day 2017: Local Health Departments Move Toward Elimination
World Hepatitis Day takes places every year on July 28 to raise awareness of the global burden of viral hepatitis and influence real...
Jul 28, 2017 | Gretchen Weiss
Treatment Action Group: 2017 Pipeline Report
Treatment Action Group (TAG) recently launched its annual research and development landscape analysis: The Pipeline Report: Drugs,...
Jul 20, 2017 | Kim Rodgers
Join Now! New HHS Hepatitis C Medicaid Affinity GroupThe Office of HIV/AIDS and Infectious Disease Policy (OHAIDP), in collaboration with the Centers for Medicare and Medicaid Services (CMS), the Centers for Disease Control and Prevention (CDC), the Health Resources and Services Administration (HRSA), and the HHS Office of Minority Health (OMH), has launched a new joint initiative: the Hepatitis C Medicaid Affinity Group. […] Oct 11, 2017 | Kim Rodgers |
HHS Blog: When it Comes to Curing Hepatitis C, Your Health Care Provider May Not Need to Be A SpecialistThis blog, written by Richard Wolitski, Ph.D., Director, Office of HIV/AIDS and Infectious Disease Policy, U.S. Department of Health and Human Services, was originally published on the Department of Health and Human Services’ Viral Hepatitis Blog. Below is a brief snippet. Summary: Study published in Annals of Internal Medicine found no differences in sustained virologic response among... Sep 28, 2017 | Kim Rodgers |
HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C (Update)The American Association for the Study of Liver Diseases (AASLD) and the Infectious Diseases Society of America (ISDA) released several significant updates to the AASLD-IDSA HCV Guidance. The latest version has been modified to reflect important developments, including the recent approvals of glecaprevir/pibrentasvir and sofosbuvir/velpatasvir/voxilaprevir. Updated recommendations reflecting... Sep 22, 2017 | Kim Rodgers |
Report: Science over Stigma: The Public Health Case Against HCV Treatment Sobriety RestrictionsIn response to the introduction of effective, short-course, curative hepatitis C (HCV) treatments, shifting HCV trends nationwide, and calls for universal access to treatment, NASTAD has recently released Science over Stigma: The Public Health Case Against HCV Treatment Sobriety Restrictions,which explores the impact of private and public insurance sobriety requirements that are barriers to HCV... Sep 14, 2017 | Kim Rodgers |
Funding Opportunity: Projects Addressing HIV/HCV in Context of Opioid EpidemicamfAR, “The Foundation for AIDS Research,” is seeking grant applicants for a funding opportunity of up to $70,000. The grant is intended to support state or local level efforts addressing HIV and/or hepatitis C in the context of the opioid crisis. Eligible organizations include health departments, substance use disorder treatment providers, organizations/networks that represent people... Aug 18, 2017 | Anastasia Sonneman |
NASTAD Call to Action: Urgent Response to Nation’s Hepatitis C EpidemicIn response to the recent National Academies of Sciences, Engineering, and Medicine’s (NASEM) release of A National Strategy for the Elimination of Hepatitis B and C: Phase Two Report, the National Association of State and Territorial AIDS Directors (NASTAD) has issued a Call to Action and accompanying Blog Post for an urgent response to the […] Aug 01, 2017 | Kim Rodgers |
NACCHO Launches Hepatitis C Public Health Detailing KitOn this World Hepatitis Day, NACCHO is pleased to launch its Hepatitis C Public Health Detailing Kit. Hepatitis C (HCV) presents a significant and growing challenge for our public health and healthcare systems. More than 3.5 million Americans are living with HCV, and the nation’s opioid epidemic is driving a surge in new infections, especially […] Jul 28, 2017 | Kim Rodgers |
World Hepatitis Day 2017: Local Health Departments Move Toward EliminationWorld Hepatitis Day takes places every year on July 28 to raise awareness of the global burden of viral hepatitis and influence real change. Viral hepatitis is a major global health threat with around 240 million people living with chronic hepatitis B virus (HBV) and up to 150 million people living with chronic hepatitis C […] Jul 28, 2017 | Gretchen Weiss |
Treatment Action Group: 2017 Pipeline ReportTreatment Action Group (TAG) recently launched its annual research and development landscape analysis: The Pipeline Report: Drugs, Diagnostics, Vaccines, Preventive Technologies, Research Toward a Cure, and Immune-Based and Gene Therapies in Development. This year’s Pipeline Report continues to demonstrate the significant yields of drugs and biologics research and the advancement of breakthrough... Jul 20, 2017 | Kim Rodgers |
Subscribe Today
Sign Up for the E-mail Digests
Create an account or login to MyNACCHO and go to "My Subscriptions."
SUBSCRIBE NOW
